Mutations of SCN4A encoding the skeletal muscle sodium channel Nav 1.4 cause several types of disease, including sodium channel myotonias. The latter may be responsible for neonatal symptoms, including severe neonatal episodic laryngospasm (SNEL). Establishing the diagnosis of SCN4A-related SNEL early in the neonatal period is crucial because treatment is available that can reduce laryngospasm and improve vital and cerebral outcome. We report 2 new unrelated French patients who presented with SNEL. The first patient was initially diagnosed with laryngomalacia and underwent laryngeal surgery in the neonatal period before being diagnosed with myotonia at 14 months of age. The episodes of laryngospasm disappeared spontaneously, although occasional circumstances such as cold exposure could trigger laryngeal reactions; in addition, he developed myotonia corresponding to an adult myotonia permanens phenotype. This patient is now 24 years old and leading a normal life. The second patient was initially diagnosed with gastroesophageal reflux, then SNEL; his condition improved with carbamazepine treatment, and he is now 6 months old. The diagnostic sequence in both patients was the same: first, severe episodic apneic attacks necessitating hospitalization occurring in the first week of life; second, observation of muscle hypertrophy and peripheral hypertonia with a clear myotonic pattern on electromyogram (at 14 and 3 months of age, respectively); third, genetic testing revealing de novo SCN4A G1306E mutation. Both patients have had good therapeutic response to sodium channel blockers (carbamazepine or mexiletine). Pediatrics 2013;132:e784-e787 AUTHORS:
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Patient 2
The patient is the first child of nonconsanguinous parents, born in March 2012. Oligohydramnios and intrauterine growth retardation were noted during the seventh month of pregnancy. Measurements at birth after 39 weeks' gestation were 2.920 kg for weight, 48 cm for height, and 34 cm for head circumference, with an Apgar score of 10/10. His parents noticed breathing difficulty from birth, and during the first week of life he presented with daily episodes of apnea; he was therefore hospitalized at 1 month of life. At this time gastroesophageal reflux was diagnosed and treated, and he went home after 2 weeks. However, frequent daily episodic dyspnea persisted, sometimes occurring more than once per hour, leading to admission to the ICU at age 3 months. In the ICU it was noted that the apneic episodes were associated with initial stridor followed by generalized stiffness, facial contraction, cyanosis, and bradycardia, generally without loss of consciousness; these episodes lasted a few seconds, with rapid recovery. Between attacks, neurologic examination showed slight peripheral hypertonia with hypertrophy of limb muscles and clenched hands; spontaneous movements were poor, without muscle weakness, and physiologic tendon reflexes were present. Psychomotor development was normal. Investigations including electroencephalography, brain imaging, and serum potassium levels were normal. Electromyography revealed permanent CASE REPORT spontaneous muscle activity with myotonic discharges (Supplemental Video 1 and Fig 1) and allowed the diagnosis of myotonic SNEL. Rapid sequencing of the SCN4A gene showed a heterozygous c.3917G.A mutation predicting a p.Gly1306Glu missense, which has previously been associated with SNEL. 8 Genetic analysis of parents confirmed that the mutation was de novo. Treatment with carbamazepine was initiated at 3.5 months, titrated up to 12 mg/kg/day. Laryngospasms diminished in frequency and intensity within 1 week, allowing discharge from hospital. One month after the beginning of treatment, only 2 or 3 daily episodes of dyspnea occurred. Clinical examination revealed persistent global hypertonia and hypertrophic muscles but better use of the hands.
DISCUSSION
We report 2 new cases of G1306E de novo mutation in SCN4A presenting with episodic laryngospasm during the first days of life. SNEL as the initial presentation of sodium muscle channelopathy has already been reported. [6] [7] [8] Correct diagnosis is crucial given the possibility of fatal outcome, although the G1306E mutation seems to have better prognosis than N1297K 7 or A799S. 8 The condition may be easily mistaken for laryngomalacia or gastroesophageal reflux, as was the case in our patients; such misdiagnosis could clearly be deleterious, eventually leading to unnecessary surgery or repeated hospitalization in the neonatal period. Thus in the presence of laryngospasm, clinical examination must be rigorous and peripheral hypertonia and hypertrophy of muscles should be sought. Altered muscle anatomy most often appears secondarily, and diagnosis is difficult during the first months of life. 8 Family history (muscle stiffness, cold-and exerciseinduced phenomena, or similar episodes in family members suggesting dominant inheritance) may offer important clues allowing earlier diagnosis, but in our 2 patients, mutations were de novo. In patient 1, the laryngospasm gradually disappeared in the second year of life. In patient 2, carbamazepine treatment produced rapid improvement. Although the case of patient 1 shows that SNEL may spontaneously disappear in the first years of life, treatment by sodium channel blockers is nevertheless appropriate because this avoids severe life-threatening events and improves myotonic symptoms.
InFrance,4casesofneonatallaryngospasm caused by G1306E de novo mutation have been diagnosed over the last 5 years, which suggests that this disorder may be more common than previously thought and probablyis underdiagnosed in infancy. The two other reported cases were effectively treated with carbamazepine in one case and mexiletine in the other. 8 Glycine on site 1306 is important for sodium channel inactivation in the a-subunit. 9 The substitution of glutamic acid for glycine is located between repeat III and IV in exon 22 and is responsible for slower sodium fast channel inactivation and an increase in late channel opening, resulting in durable muscle depolarization and muscle fiber hyperexcitability. This G1306E substitution is associated with the most intense form of sodium channel myotonia, myotonia permanens. 10 Cold sensitivity may be observed in this condition, and respiratory involvement is possible although not common. 10 Other substitutions at this codon (glycine to valine, glycine to alanine) have milder biophysical effects and are associated with a milder form of sodium channel myotonia, myotonia fluctuans, 11 in which no neonatal symptoms have been reported. Electromyography is a sensitive and specific tool permitting diagnosis of electrical myotonia in patients with episodes of stiffness. It shows a unique pattern in children and adults with SCN4A G1306E-related myotonia permanens 10 characterized by abundant largeamplitude rhythmic discharges that are spontaneous, permanent, and ubiquitous. This myotonic activity is triggered by insertion of the fine needle electrode but also by external sources of excitation. Myotonic discharges are high-amplitude positive sharp waves and constitute complex repetitive discharges (Fig 1) . Supplementary material can be found at:
